Huixing Yuan

Statistical Study Lead
Sanofi, Cambridge, MA, USA
Cambridge, Massachusetts, United States

Presentation(s):

• LB 01.1 - Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age With Severe Hemophilia A

  Sunday, June 25, 2023
  10:45 – 11:00 ET